Evidence map›Paper›PMID 29350330›Full record

SynthesisClinical rheumatology2018

Role of dual-energy CT in the diagnosis and follow-up of gout: systematic analysis of the literature.

André Ramon, Amélie Bohm-Sigrand, Pierre Pottecher, Pascal Richette, Jean-Francis Maillefert, Herve Devilliers, Paul Ornetti

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Endoscopic management of lumbar spinal tophaceous gout: six cases treated with percutaneous transforaminal (PTED) and interlaminar (PIED) discectomy and a literature review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Review
  5. Article
  6. Computed tomography-current status and future directions for arthritis imaging.Therapeutic advances in musculoskeletal disease · 2024
    Review
  7. Costochondral gout.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  8. Article
  9. A glance into the future of gout.Therapeutic advances in musculoskeletal disease · 2022
    Review
  10. Article
  11. Article
  12. What Has Dual Energy CT Taught Us About Gout?Current rheumatology reports · 2021
    Review
  13. [CT spectral curve in differentiating spinal tumor metastasis and infections].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2020
    Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

André RamonDepartment of Rheumatology, Dijon University Hospital, 14 rue Gaffarel, 21000, Dijon, France.
Amélie Bohm-SigrandDepartment of Rheumatology, Dijon University Hospital, 14 rue Gaffarel, 21000, Dijon, France.
Pierre PottecherDepartment of Radiology, Section of Musculoskeletal Imaging and Intervention, Dijon University Hospital, Dijon, France.
Pascal RichetteINSERM U1132 and University Paris-Diderot, Paris, France.
Jean-Francis MaillefertDepartment of Rheumatology, Dijon University Hospital, 14 rue Gaffarel, 21000, Dijon, France.
Herve DevilliersDepartment of Internal Medicine, Dijon University Hospital, Dijon, France.
Paul OrnettiDepartment of Rheumatology, Dijon University Hospital, 14 rue Gaffarel, 21000, Dijon, France. paul.ornetti@chu-dijon.fr.
Inserm · FRCHU Dijon Bourgogne · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this systematic review was to determine the potential role of dual-energy CT in the diagnosis and follow-up of gout with regard to the Outcome Measures in Rheumatology (OMERACT) filter. A systematic analysis of the literature was conducted using the MEDLINE and Cochrane databases and published abstracts of international congresses, according to the criteria of the OMERACT filter: feasibility, reproducibility, validity versus laboratory (serum urate, MSU synovial fluid aspirate) and other imaging modalities for gout, and its sensitivity to change in patients on urate lowering therapy (ULT). Thirty-two articles were found representing a total of 1502 patients. The data on feasibility showed that the examination took little time and involved low levels of radiation but had current limited availability. Intra- and inter-observer reproducibility was excellent, with intra-class correlation coefficients > 0.9. Validity in comparison with polarized-light microscopy showed good sensitivity and specificity (> 80%). The diagnostic performance was better than that of radiography and conventional CT-scan and at least equivalent to that of ultrasonography. The sensitivity to change varied with effect sizes from 0.05 (low) to 1.24 (high) for decrease in the tophus volume following different ULT in gout patients. Dual-energy CT-scan is a reproducible and accurate imaging modality for the diagnosis of gout, particularly for tophaceous gout (intra- or extra-articular). It can become a second-line imaging modality of choice in cases of diagnostic doubt, such as ultrasonography. Its role remains uncertain in the follow-up of gout patients treated with ULT and needs further clarification.

Indexed as

Disease ProgressionGoutHumansSeverity of Illness IndexTomography, X-Ray ComputedDual-energy CTGoutImagingPsychometric propertiesSystematic analysis

Identifiers

PMID29350330
OpenAlexW2788757640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.